Author

L. Pantano

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

A. C. Mullen· 2 shared C. Sun· 2 shared D. Wrobel· 2 shared J. F. Doerner· 2 shared J. F. Rippmann· 2 shared J. Y. Chen· 2 shared R. Kirchner· 2 shared R. P. Sparks· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. C. Mullen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells

W. Li, R. P. Sparks, C. Sun, Y. Yang, L. Pantano, R. Kirchner, A. Weilheimer, B. J. Toles, J. Y. Chen, S. P. Moran, V. Barrera, Z. Li, P. Zhou, M. L. Brassil, D. Wrobel, , A. C. Mullen

The paper identifies ABHD17B as a therapeutic target for liver fibrosis by showing its depletion inactivates hepatic stellate cells and reduces fibrosis in mice.

bioRxiv · Aug 7, 2023Cell Biology

Nanchangmycin regulates FYN, FAK and ERK to control the fibrotic activity of hepatic stellate cells

W. Li, J. Y. Chen, C. Sun, R. P. Sparks, L. Pantano, R.-U. Rahman, S. P. Moran, J. V. Pondick, R. Kirchner, D. Wrobel, M. Bieler, S. J. Ho Sui, J. F. Doerner, J. F. Rippmann, A. C. Mullen

This study identifies nanchangmycin as an anti-fibrotic agent that inhibits HSC myofibroblast activity by modulating FYN, FAK, and ERK signaling pathways.

bioRxiv · Oct 8, 2021Cell Biology